1Thomas D, Kathofer S, Zhang W, et al. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels. Br J Pharmacol,2003,140:996-1002.
2Shingawa K, Shiroshita-Takeshita A, Schram G, et al. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium:insights into the mechanism of the superior efficacy of amiodarone. Circulation,2003,107:1440-1446.
3Haikerwal D, Esler MD, Dart AM. Acute electrophysiologic effects of intravenous amiodarone are independent of a sympatholytic action in humans. J Cardiovasc Pharmacol, 2003,41:760-765.
4Letelier LM, Udol K, Ena J, et al. Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a metaanalysis. Arch Intern Med,2003 ,163 :777-785.
5Khan IA, Mehta NJ, Gowda RM. Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol, 2003,89: 239-248.
6Bernard EO, Schmid ER, SchmidlinD, et al. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Crit Care Med,2003,31:1031-1034.
7Naccarelli GV,Wolbretted L,Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation:comparative efficacy and results of trials. Am J Cardiol,2003,91 (Suppl): 15D-26D.
8Levy S. Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint. Cardiovascdrugs Ther, 1994,8: 769 -771.
9Fuster V,Ryde'n LE,Asinger RW,et al,for the Committee to develop Guidelines for the Management of Patients with Atrial Fibrillation Investigators. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation: executive Summary. Circulation ,2001,104:2118-2150.
10Roy D,Talajic M,Dorian P,et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med ,2000,342:913-920.
